Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis.
Cumali EfeCraig Steven LammertKoray TaşçılarRenumathy DhanasekaranBerat EbikFatima Higuera-de la TijeraAli Rıza CalışkanMirta PeraltaAlessio GerussiHatef MassoumiAndreea M CatanaTugrul PurnakCristina RigamontiAndres Jose Gomez AldanaNidah KhakooLeyla NazalShalom FragerNurhan DemirKader IrakZeynep Melekoğlu EllikHüseyin KacmazYasemin BalabanKadri AtayFatih ErenMario Reis Alvares-da-SilvaLaura CristoferiÁlvaro UrzuaTuğçe EşkazanBianca MagroRomee SnijdersSezgin BarutçuEllina LytvyakGodolfino Miranda ZazuetaAylin Demirezer BolatMesut AydınAlexandra Heurgue-BerlotEleonora De MartinNazım EkinSümeyra YıldırımAhmet YavuzMurat BıyıkGraciela Castro NarroMurat KıyıcıMurat AkyıldızEvrim Kahramanoğlu-AksoyMaria VincentRotonya M CarrFulya GünşarEira Cerda ReyesMurat HarputoğluCostica AlomanNikolaos K GatselisYücel ÜstündağJavier BrahmNataly Chris Escajadillo VargasFatih GuzelbulutSandro Ruiz GarciaJonathan AguirreMargarita AndersNatalia RatusnuIbrahim HatemiManuel MendizabalAnnarosa FloreaniStefano FagiuoliMarcelo SilvaRamazan IdilmanSanjaya Kumar SatapathyMarina SilveiraJoost Paulus Hubertus DrenthGeorge N DalekosDavid N AssisEinar Stefan BjörnssonJames L BoyerEric M YoshidaInvernizzi PietroCynthia LevyAldo J Montano-LozaThomas D SchianoEzequiel RidruejoStaffan WahlinPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Baseline treatment with systemic glucocorticoids or thiopurines prior to the onset of COVID-19 was significantly associated with COVID-19 severity in patients with AIH.